Clinical Studies

Some patients are treated in the IHBT in the framework of clinical studies. Innovative medical preparations frequently represent the only therapeutic option that can be offered to a patient. For the inclusion in clinical evaluation it is necessary to meet all inclusion conditions, the so-called entry criteria. Before entering clinical evaluation, patients get acquainted in detail with its conditions and course. Involvement in clinical studies is voluntary and the start is bound to the patient’s signature to informed consent. Supervision over clinical evaluation is performed strictly both by the clinical study contractor and other inspecting authorities (a local Ethics Committee, Multi-Centric Ethics Committee, State Institute for Drug Control).

At present more than twenty clinical studies are in progress in the IHBT Clinical Department. They are focused mainly on diseases whose treatment represents core therapeutic programs of the IHBT:

• Myelodysplastic syndrome
• Chronic myeloid leukemia
• Acute myeloid leukemia
• Acute lymphoblastic leukemia
• Hemopoietic cell transplant
• Idiopathic thrombocytopenic purpura

Quick contact

Stem cell transplant coordinator
+420 221 977 486

Transplant Unit
+420 221 977 229

+420 221 977 315

Inpatient Department
+420 221 977 226

+420 221 977 294

Opening hours

Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Inpatient departments
Non stop

How to find us


Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here